-
公开(公告)号:US20210315868A1
公开(公告)日:2021-10-14
申请号:US16640146
申请日:2018-08-24
发明人: Frederic GEISSMANN , Elvira MASS , Rocio VICARIO
IPC分类号: A61K31/437 , A61K45/06 , A61P25/28
摘要: The present technology relates to methods for treating, preventing, and/or ameliorating kinase mutation-associated neurodegenerative diseases, including BRAFV600E-associated neurodegenerative diseases, in a subject in need thereof. In particular aspects, the present technology relates to the use of BRAF, MEK, and/or CSF-IR inhibitors to treat, prevent, and/or ameliorate kinase mutation-associated neurodegenerative diseases, including BRAFV600E-associated neurodegenerative diseases.
-
公开(公告)号:US20230277512A1
公开(公告)日:2023-09-07
申请号:US17751226
申请日:2022-05-23
发明人: Frederic GEISSMANN , Elvira MASS , Rocio VICARIO
IPC分类号: A61K31/437 , A61P25/28 , A61K45/06
CPC分类号: A61K31/437 , A61P25/28 , A61K45/06
摘要: The present technology relates to methods for treating, preventing, and/or ameliorating kinase mutation-associated neurodegenerative diseases, including BRAFV600E-associated neurodegenerative diseases, in a subject in need thereof. In particular aspects, the present technology relates to the use of BRAF, MEK, and/or CSF-1R inhibitors to treat, prevent, and/or ameliorate kinase mutation-associated neurodegenerative diseases, including BRAFV600E-associated neurodegenerative diseases.
-